All news

Biogen's Chief Accounting Officer Sean Godbout Reports October 2026 Stock Transactions via Form 4

Alpha Vantage · Kalkine Media · · AI-summarised by FinFlash

Biogen's Chief Accounting Officer Sean Godbout filed a Form 4 detailing his October 2026 equity transactions. These included the grant of 985 restricted stock units, the conversion of 27 RSUs into common stock, and the sale of 8 shares to cover tax withholdings. Following these transactions, Godbout directly held 1,458.9845 shares of Biogen common stock.

Read original source

BIIB company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.